James Gordon Still, MD, PhD
Chief Medical Officer
Dr. Gordon Still provides clinical expertise to the antifungal development programs in his role as Chief Medical Officer. Over the previous 5 years, he has provided medical leadership and safety management in all of the VT-1161 clinical trials for Viamet Pharmaceuticals. In addition to his position at Mycovia Pharmaceuticals, Dr. Still serves as an independent medical consultant, providing strategic clinical development leadership and consulting for pharmaceutical, biotechnology and medical device clients in a variety of therapeutic areas.
Dr. Still is board-certified in Pediatrics and a Fellow of the American Academy of Pediatrics. His clinical research activities in both academic and industry settings have centered primarily on the treatment and prevention of infectious diseases and he has authored or co-authored numerous publications on basic and clinical research of new therapeutic agents.
Dr. Still holds a BS from Virginia Polytechnic Institute and State University, an MD from The Bowman Gray School of Medicine of Wake Forest University and a PhD from Wake Forest University.